Abstract
A young schizophrenic patient developed cholestatic jaundice and agranulocytosis during chlorpromazine (CPZ) therapy. Mechanisms responsible for these complications are discussed.
MeSH terms
-
Acute Disease
-
Adult
-
Agranulocytosis / chemically induced*
-
Agranulocytosis / pathology
-
Chlorpromazine / adverse effects*
-
Cholestasis / chemically induced*
-
Cholestasis / pathology
-
Female
-
Humans
-
Schizophrenia / complications
-
Schizophrenia / drug therapy